참고문헌
- Urist MR. Bone: formation by autoinduction. Science 1965;150:893-899 https://doi.org/10.1126/science.150.3698.893
- Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-1534 https://doi.org/10.1126/science.3201241
- Celeste AJ, Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor-family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 1990;87:9843-9847
- Kim CS, Choi SH, Choi BK, et al. The effect of recombinant human bone morphogenetic protein-4 on the osteoblastic differentiation of mouse calvarial cells affected by Porphyromonas gingivalis. J Periodontol 2002;73:1126-1132 https://doi.org/10.1902/jop.2002.73.10.1126
- Wikesjo UM, Guglielmoni P, Promsudthi A, et al. Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 1999;26:392-400 https://doi.org/10.1034/j.1600-051X.1999.260610.x
- Kingsley DM, Bland AE, Grubber JM, et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF superfamily. Cell 1992;71:399-410 https://doi.org/10.1016/0092-8674(92)90510-J
- Solloway MJ, Dudley AT, Bikoff EK, et al. Mice lacking BMP-6 function. Dev Genet 1998;22:321-323 https://doi.org/10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.0.CO;2-8
- Jena N, Martin-Seisdedos C, McCue P, et al. BMP7 null mutation in mice: Developmental defects in skeleton, kidney, and eye. Exp Cell Res 1997;230:28-37 https://doi.org/10.1006/excr.1996.3411
- Sampath TK, Maliakal JC, Hauschka PV, et al. Recombinant human osteo-genic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-20362
- Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990;87:2220-2224 https://doi.org/10.1073/pnas.87.6.2220
- Cook SD, Salkeld SL, Patron LP. Bone defect healing with an osteogenic protein-1 device combined with carboxymethylcellulose. J Biomed Mater Res Appl Biomater 2005;75:137-145
- Cook SD, Baffes GC, Wolfe MW, et al. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 1994;176:827-838
- Cook SD, Wolfe MW, Salkeld SL, Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 1995;77:734-750 https://doi.org/10.2106/00004623-199505000-00010
- Reddi AH. Bone Morphogenetic Proteins: From Basic Science to Clinical Applications. J Bone Joint Surg Am 2001;83:S1 - S6 https://doi.org/10.1302/0301-620X.83B1.11892
- Griffith DL, Keck PC, Sampath TK, et al. Three- dimensional structure of recombinant human osteogenic protein 1 : Structural paradigm for the transforming growth factor superfamily. Proc Natl Acad Sci USA 1996;93:878-883
- Hong SJ, Kim CS, Jung UW, et al. Fibrin-Fibronectin Sealing System in Combination with -Tricalcium Phosphate as a Carrier for Recombinant Human Bone Morphogenetic Protein-2: Effects on Bone Formation in Rat Calvarial Defects. Biomaterials 2005;27:3810-3816 https://doi.org/10.1016/j.biomaterials.2006.02.045
- Hyun SJ, Choi SH, Chai JK, et al. The effect of recombinant human bone morphogenetic protein-2, 4 and 7 on bone formation in rat calvarial defects. J Periodontol 2005;76:1-8 https://doi.org/10.1902/jop.2005.76.1.1
- Choi SH, Kim CK, Cho KS, et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63-72 https://doi.org/10.1902/jop.2002.73.1.63
- Pang EK, Im SU, Kim CS, et al. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in rat calvarial defects. J Periodontol 2004;75:1364-1370 https://doi.org/10.1902/jop.2004.75.10.1364
- Ahn SH, Kim CS, Suk HJ, et al. Effect of Recombinant Human Bone Morphogenetic Protein- 4 with Carriers in Rat Calvarial Defects. J Periodontol 2003;74:787-797 https://doi.org/10.1902/jop.2003.74.6.787
- Frankel AD, Pabo CO. Cellular uptake of the TAT protein from human immunodeficiency virus. Cell 1988;55:1189 -1193 https://doi.org/10.1016/0092-8674(88)90263-2
- Watson K, Edwards RJ. HIV-1-trans-activating(TAT) protein both a target and a tool in therapeutic approaches. Biochem Pharmacol 1999;58:1521-1528 https://doi.org/10.1016/S0006-2952(99)00209-9
- Lindgren M, Halbrink M, Prochiantz A, Langel U. Cell penetrating peptides. Trends Pharmacol Sci 2000;21:99-103 https://doi.org/10.1016/S0165-6147(00)01447-4
- Schwarze SR, Hruska KA, Dowdy SF. Protein transduction : unrestricted delivery into all cell? Trends cell Biol 2000;10:290-295 https://doi.org/10.1016/S0962-8924(00)01771-2
- Schwarze SR, Dowdy SF. In vivo protein transduction : intercellular delivery of biological active proteins. componds and DNA. Trends Pharmacol Sci 2000;21:45-48 https://doi.org/10.1016/S0165-6147(99)01429-7
- Fawell S, Seery J, Daikh Y, et al. TAT- mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 1994;91:664-668 https://doi.org/10.1073/pnas.91.2.664
- Nagahara H, Vocero-Akbani AM, Snyder EL, et al. Transduction of full- length TAT union proteins into mammalian cells: TAT -p27Kip1 induces cell migration. Nat Med 1998;4:1449-1452 https://doi.org/10.1038/4042
- Jung SW, Kim NH, Yook JI, et al. Bone regenerative effects of recombinant human bone morphogentic protein-2 employed protein transduction domain. J Korean Acad Periodontol 2007;37:497-509 https://doi.org/10.5051/jkape.2007.37.3.497
- Han DK, Kim CS, Cho KS. Effect of a Fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2005;76:2216-2222 https://doi.org/10.1902/jop.2005.76.12.2216
- Kim CS, Kim JI, Kim J, et al. Ectopic bone formation associated with recombinanthuman bone morphogenetic protein-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2004;19:1-7
- Urist MR, Lietze A, Dawson E. Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop 1984;187:277-280
- Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunion. Clin Orthop 1986;205:299-308
- King GN, Cochran DL. Factors that modulate the effect of bone morphogenetic protein-induced periodontal regeneration; a critical review. J Periodontol 2002;73:925-936 https://doi.org/10.1902/jop.2002.73.8.925
- Yasco AW, Lane JM, Fellinger EJ. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg Am 1992;74-A:659-671
- Barboza EP, Duarte ME, Geolas L, et al. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000;71:488-496 https://doi.org/10.1902/jop.2000.71.3.488
- Frankel AD, Pabo CO. Cellular uptake of the TAT protein from human immunodeficiency virus. Cell 1988;55:1189 -1193 https://doi.org/10.1016/0092-8674(88)90263-2
- Maurice Green, and Paul M. Loewenstein. Autonomous Functional Domains of Chemically Synthesized Human Immunodeficiency Virus Tat Trans-Activator Protein. Cell 1988;55:1179-1188 https://doi.org/10.1016/0092-8674(88)90262-0
- Ford KG, Souberbielle BE, Darling D, Farzaneh F. Protein transduction: an alternative to genetic intervention? Gene therapy 2001;8:1-4 https://doi.org/10.1038/sj.gt.3301383
- Leifert LA, Whitton JL. "Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanism. Mol Ther 2003;8:13-20 https://doi.org/10.1016/S1525-0016(03)00151-5
- Ozkaynak E, Rueger DC, Drier EA, et al. Op-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 1990;9:2085-2093
- Takakis DN, Koh A, Jin L, et al. Peri-implant bone regenerationusing recombinant human bone morphogenetic protein-2 in a canine model: A dose-response study. J Periodontal Res 2002;37:93-100 https://doi.org/10.1034/j.1600-0765.2002.00021.x
- Sandhu HS, Kanim LE, Kabo JM, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996;21:2115-2122 https://doi.org/10.1097/00007632-199609150-00012
- Jehangir SW, Radu VS, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature medicine 2004;10:311-315